Ruxolitinib Is More Effective than Other Jak Inhibitors to Treat Vexas Syndrome: a Retrospective Multicenter Study

AuthID
P-00X-ASM
25
Author(s)
Ferrada, MA
·
Koster, MT
·
Barba, T
·
Gerfaud Valentin, M
·
Mekinian, A
·
Coelho, H
·
Barraco, F
·
Galicier, L
·
[+1]·
[+4]·
Bigot, A
·
Warrington, KJ
·
Kermani, TA
·
Grayson, PC
·
Patel, BA
·
Beck, DB
·
Document Type
Letter
Year published
2022
Published
in BLOOD, ISSN: 0006-4971
Volume: 140, Issue: 8, Pages: 927-931 (5)
Indexing
Publication Identifiers
Pubmed: 35609174
Wos: WOS:000862865900019
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Heiblig, M;   2 Ferrada, MA;   3 Koster, MT;
4 Barba, T;   5 Gerfaud Valentin, M;   6 Mekinian, A;
7 Coelho, H;   8 Fossard, G;   9 Barraco, F;
10 Galicier, L;   11 Bienvenu, B;   12 Hirsch, P;
13 Vial, G;   14 Boutin, AB;   15 Galland, J;
16 Le Guenno, G;   17 Bigot, A;   18 Warrington, KJ;
19 Kermani, TA;   20 Grayson, PC;   21 Patel, BA;
22 Beck, DB;   23 Jamilloux, Y;   24 Fenaux, P;
25 Sujobert, P;